PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $19,500,000 | -47.5% | 1,915,568 | -23.2% | 0.36% | -50.7% |
| Q2 2020 | $37,171,000 | -5.9% | 2,494,691 | -23.0% | 0.72% | -42.0% |
| Q1 2020 | $39,502,000 | -25.8% | 3,240,534 | -3.7% | 1.25% | -22.7% |
| Q4 2019 | $53,246,000 | +28.9% | 3,363,605 | 0.0% | 1.62% | -34.4% |
| Q3 2019 | $41,305,000 | +14.1% | 3,363,605 | +22.6% | 2.46% | +26.6% |
| Q2 2019 | $36,216,000 | – | 2,743,625 | – | 1.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|